Results 121 to 130 of about 48,040 (220)

Anti‐Modified Protein Antibodies in Rheumatoid Arthritis: Pathogenic, Protective, or Passive Bystander?

open access: yesImmunological Reviews, Volume 341, Issue 1, August 2026.
ABSTRACT The presence of anti‐modified protein antibodies (AMPA) is a hallmark of rheumatoid arthritis (RA). AMPA recognize post‐translationally modified proteins and are cross‐reactive. AMPA include anti‐citrullinated protein antibodies (ACPA), anti‐carbamylated protein antibodies (anti‐CarP), and anti‐acetylated protein antibodies (AAPA).
Amber‐Sarai F. L. Stalman   +1 more
wiley   +1 more source

Changes in Aperiodic (1/f Slope) Activity During a Picture‐Word Interference Task: Effects of Congruency and Sequence Manipulations

open access: yesPsychophysiology, Volume 63, Issue 8, August 2026.
ABSTRACT Aperiodic neural activity (1/f EEG) has been proposed to reflect the balance between excitatory and inhibitory (E/I) inputs, with steeper spectral slopes reflecting increased inhibition and flatter slopes indicating excitation. This activity is also thought to reflect the temporal coordination of neural firing, offering insights into ...
Virginia Tronelli   +7 more
wiley   +1 more source

CaV1.2 dynamics in native male arterial myocytes

open access: yesThe Journal of Physiology, Volume 604, Issue 15, Page 6302-6323, 1 August 2026.
Abstract figure legend Proposed model of microtubule‐dependent CaV1.2 reorganization in vascular disease. Schematic illustration of microtubule‐mediated delivery and stabilization of CaV1.2 channels into enlarged plasma membrane clusters in response to Ang II or hyperglycaemia, promoting cooperative gating and enhanced Ca2+ influx. Abstract L‐type CaV1.
Miguel Martin‐Aragon Baudel   +9 more
wiley   +1 more source

Editorial: Cross-talk of synaptic proteins in neurological diseases. [PDF]

open access: yesFront Neurol
Annamneedi A   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy